Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group
Kevin Campbell, Arlene Naranjo, Emily Hibbitts, Julie M. Gastier‐Foster, Rochelle Bagatell, Meredith S. Irwin, Hiroyuki Shimada, Michael D. Hogarty, Julie R. Park, Steven G. DuBois
Topics & Concepts
HomogeneousNeuroblastomaMedicineInternal medicineOncologyOverall survivalLoss of heterozygosityProportional hazards modelBiologyGeneAlleleCell cultureGeneticsPhysicsThermodynamicsNeuroblastoma Research and TreatmentsCancer, Hypoxia, and MetabolismCancer therapeutics and mechanisms